Radical cystectomy is associated with better survival, but findings suggest BPT may produce acceptable oncologic outcomes in appropriately selected patients.
Researchers find no significant change in overall complication rate from 2010 to 2015, but hospital length of stay and need for transfusion have declined.
Meta-analysis reveals no significant difference in overall-, disease-specific, and progression-free survival between radical cystectomy and radiation-based, bladder preservation therapy.
After recurrent disease, 5-year overall survival was worse among patients with late recurrence.
The researchers found lower overall survival among patients undergoing robot-assisted radical cystectomy at hospitals performing 10 or fewer procedures during 2010 to 2012.
By 2014 to 2015, 1 in 3 bladder cancer surgical procedures performed in the United States were robot-assisted.
Radical cystectomy is associated with better long-term overall survival than trimodal therapy, new study shows.
Finding contrasts with results of randomized clinical trials.
Nomograms specific to radical cystectomy currently do not exist to aid stratification of a patient's risks for complications.
In a study, 53.1% of patients had concomitant prostate cancer in radical cystectomy specimens.
Predictors of distant recurrences after robot-assisted radical cystectomy were mainly dictated by pathological tumor characteristics.
Researchers find no difference in 5-year disease-specific survival between multi-disciplinary bladder-sparing approach and radical cystectomy.
During first 24 months, 8.7% of patients with favorable pathological characteristics had progressed.
Patients who underwent debulking had significantly longer overall survival compared with those who did not (median 15.7 vs 10 months).
Mortality risk decreases with increasingly stringent BPT compared with radical cystectomy.
Cancer-specific survival at 5 years was 76.9% for men and 71.5% for women.
The timing of office visits and telephone calls helped identify a patient at risk for readmission post-radical cystectomy.
Shorter operating time is one advantage of cutaneous ureterostomy with a single stoma.
The guidelines were assessed for developmental rigor, and the ASCO endorsed all but one of the guidelines.
Current smoking is independently associated with a greater than 2-fold increased odds of hospital readmission after radical cystectomy.
The more risk factors patients have, the greater their risk of serious perioperative complications.
Patients with venous thromboembolism tended to die earlier from their bladder cancer.
Improved survival with adjuvant chemotherapy in patients with locally advanced disease compared with cystectomy alone.
Researchers estimate that 40% of pathologic response in MIBC patients receiving both neoadjuvant chemo and TURBT is due to TURBT.
A travel distance of more than 30 miles to the provider was associated with greater chances of readmission in one analysis.
Lower patient-reported mental health was statistically associated with an increased incidence of high-grade complications after radical cystectomy.
The procedure takes longer than open radical cystectomy, but is associated with less blood loss, fewer transfusions, and shorter hospital stays.
Researchers report a significant drop in 30-day post-operative infection rate.
In a small study, 56% of NMIBC patients who received the dual regimen after failing treatment with BCG alone were tumor free.
ABO blood may be useful in risk-stratification of patients who may benefit from more aggressive treatment and/or altered surveillance regimens.
Renal and Urology News Articles
- For Treating Uremic Pruritus, Evidence is Strongest for Gabapentin
- IgG-Degrading Enzyme Desensitizes, Permits HLA-Incompatible Transplant
- Evaluating Practice Options in the Shifting Health Care Landscape
- Melanoma Risk Higher in Kidney Transplant Recipients
- Kidneys From Octogenarian Donors Show Similar Survival
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)